Overcoming functional and translational challenges of cellular immunotherapies for solid tumors - PubMed
3 hours ago
- #immunotherapy
- #solid tumors
- #cellular therapy
- Immunotherapy has revolutionized cancer treatment, offering new hope for patients.
- Cell-based therapies, including engineered T cells, NK cells, and stem cells, show promise in leveraging immune cells to target cancer.
- Despite success in hematologic malignancies, significant challenges remain in applying these therapies to solid tumors.
- Key challenges include functional limitations and translational hurdles in clinical development.
- Potential solutions involve innovative engineering, combination therapies, and emerging technologies to enhance efficacy.
- Conflict of interest disclosures highlight industry ties among some authors.